|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Mar―01 |
Discriminating promiscuous from target-specific autoantibodies in COVID-19 |
Mikhail Lebedin, Clara Vázquez García, Lisa Spatt, Christoph Ratswohl, Charlotte Thibeault, Lennard Ostendorf, et al. (+5) Tobias Alexander, Friedemann Paul, Leif Erik Sander, Florian Kurth, Kathrin de la Rosa |
2 |
[GO] |
2023―Jan―20 |
Antibody isotype epitope mapping of SARS-CoV-2 Spike RBD protein: targets for COVID-19 symptomatology and disease control |
Marinela Contreras, Joaquín Vicente, José Joaquín Cerón, Silvia Martinez Subiela, José Miguel Urra, Francisco J. Rodríguez-del-Río, et al. (+7) Elisa Ferreras-Colino, Rita Vaz-Rodrigues, Isabel G. Fernández de Mera, Sandra Antunes, Ana Domingos, Christian Gortázar, José de la Fuente |
3 |
[GO] |
2022―Nov―21 |
Distinct and dynamic activation profiles of circulating dendritic cells and monocytes in mild COVID-19 and after yellow fever vaccination |
Elena Winheim, Tabea Eser, Flora Deák, Mohamed I. M. Ahmed, Olga Baranov, Linus Rinke, et al. (+15) Katharina Eisenächer, Antonio Santos-Peral, Hadi Karimzadeh, Michael Pritsch, Clemens Scherer, Maximilian Muenchhoff, Johannes C. Hellmuth, Michael von Bergwelt-Baildon, Laura Olbrich, Michael Hoelscher, Andreas Wieser, Inge Kroidl, Simon Rothenfusser, Christof Geldmacher, Anne B. Krug |
4 |
[GO] |
2022―Oct―22 |
IL-13 determines specific IgE responses and SARS-CoV-2 immunity after mild COVID-19 and novel mRNA vaccination |
Stefan Meltendorf, Katrin Vogel, Christoph Thurm, Florian Prätsch, Annegret Reinhold, Jacqueline Färber, et al. (+8) Hans-Gert Heuft, Achim J. Kaasch, Thomas Hachenberg, Stefan Weinzierl, Burkhart Schraven, Dirk Reinhold, Monika C. Brunner-Weinzierl, Holger Lingel |
5 |
[GO] |
2022―Oct―14 |
Neutrophil Activation and Neutrophil Extracellular Traps (Nets) in COVID-19 ARDS and Immunothrombosis |
Maria Candida Cesta, Mara Zippoli, Carolina Marsiglia, Elizabeth M. Gavioli, Giada Cremonesi, Akram Khan, et al. (+3) Flavio Mantelli, Marcello Allegretti, Robert Balk |
6 |
[GO] |
2022―Sep―15 |
Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice |
Patricia P. Ogger, Minerva Garcia Martín, Christina Michalaki, Jie Zhou, Jonathan C. Brown, Yue Du, et al. (+6) Kamran M. Miah, Omar Habib, Stephen C. Hyde, Deborah R. Gill, Wendy S. Barclay, Cecilia Johansson |
7 |
[GO] |
2022―Aug―17 |
Humanized mice for investigating SARS-CoV-2 lung infection and associated human immune responses |
Renren Sun, Zongzheng Zhao, Cong Fu, Yixin Wang, Zhendong Guo, Chunmao Zhang, et al. (+8) Lina Liu, Cheng Zhang, Chang Shu, Jin He, Yong-Guang Yang, Shucheng Hua, Yuwei Gao, Zheng Hu |
8 |
[GO] |
2022―Jul―14 |
Autoimmunity and SARS-CoV-2 infection: unraveling the link in neurological disorders |
Daniela Latorre |
9 |
[GO] |
2022―Jun―11 |
COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions |
Irene T. Schrijver, Charlotte Théroude, Nikolaos Antonakos, Jean Regina, Didier Le Roy, Pierre-Alexandre Bart, et al. (+5) Jean-Daniel Chiche, Matthieu Perreau, Giuseppe Pantaleo, Thierry Calandra, Thierry Roger |
10 |
[GO] |
2022―May―07 |
Differential susceptibility to SARS-CoV-2 in the normal nasal mucosa and in chronic sinusitis |
Zhili Zhang, Haoran Peng, Ju Lai, Liangliang Jiang, Liefu Wang, Shengkai Jin, et al. (+7) Kai Fan, Zimu Zhang, Chuanliang Zhao, Dan Deng, Ping Zhao, Zhengliang Gao, Shaoqing Yu |
11 |
[GO] |
2022―May―02 |
Alterations of blood monocyte subset distribution and surface phenotype are linked to infection severity in COVID-19 inpatients |
David Haschka, Verena Petzer, Francesco Robert Burkert, Gernot Fritsche, Sophie Wildner, Rosa Bellmann-Weiler, et al. (+2) Piotr Tymoszuk, Guenter Weiss |
12 |
[GO] |
2022―Apr―14 |
Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity |
Federica Frasca, Mirko Scordio, Letizia Santinelli, Lucia Gabriele, Orietta Gandini, Anna Criniti, et al. (+7) Alessandra Pierangeli, Antonio Angeloni, Claudio M. Mastroianni, Gabriella d'Ettorre, Raphael P. Viscidi, Guido Antonelli, Carolina Scagnolari |
13 |
[GO] |
2022―Apr―13 |
Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients |
Kerri Hagemann, Kristoffer Riecken, Johannes Jung, Heike Hildebrandt, Stephan Menzel, Madeleine Bunders, et al. (+9) Boris Fehse, Friedrich Koch-Nolte, Fabian Heinrich, Sven Peine, Julian Schulze zur Wiesch, Thomas T. Brehm, Marylyn M. Addo, Marc Lütgehetmann, Marcus Altfeld |
14 |
[GO] |
2022―Apr―07 |
SARS-CoV-2 specific T-cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination |
Andrea Jarisch, Eliza Wiercinska, Shabnam Daqiq-Mirdad, Helen Hellstern, Salem Ajib, Anjali Cremer, et al. (+10) Ngoc Thien Thu Nguyen, Alexandra Dukat, Evelyn Ullrich, Sandra Ciesek, Kai-Uwe Chow, Hubert Serve, Erhard Seifried, Peter Bader, Halvard Bönig, Gesine Bug |
15 |
[GO] |
2022―Apr―06 |
COVID-19 vaccines - common misperceptions, false claims and myths explained |
Carsten Watzl |
16 |
[GO] |
2022―Mar―21 |
Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects |
Anu Haveri, Anna Solastie, Nina Ekström, Pamela Österlund, Hanna Nohynek, Tuomo Nieminen, et al. (+2) Arto A. Palmu, Merit Melin |
17 |
[GO] |
2022―Mar―21 |
Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity |
Manuel M. Vicente, Inês Alves, Joana Gaifem, Cláudia S. Rodrigues, Ângela Fernandes, Ana M. Dias, et al. (+12) Jerko Štambuk, Tea Petrović, Pedro Oliveira, Frederico Ferreira-da-Silva, Adriana Soares, Nair Seixas, Tiago Teixeira, Luis Malheiro, Miguel M. Abreu, Gordan Lauc, Rui Sarmento e Castro, Salomé S. Pinho |
18 |
[GO] |
2022―Mar―07 |
Augmented Neutralization of SARS-CoV-2 Omicron Variant by Boost Vaccination and Monoclonal Antibodies |
Sebastian R. Schulz, Markus Hoffmann, Edith Roth, Katharina Pracht, Deborah L. Burnett, Ohan Mazigi, et al. (+7) Wolfgang Schuh, Bernhard Manger, Dirk Mielenz, Christopher C. Goodnow, Daniel Christ, Stefan Pöhlmann, Hans-Martin Jäck |
19 |
[GO] |
2022―Mar―05 |
Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccination |
Doris Urlaub, Natalie Wolfsdorff, Jan-Erik Hoffmann, Stefanie Dorok, Markus Hoffmann, Moritz Anft, et al. (+15) Naomi Pieris, Patrick Günther, Bernhard Schaaf, Uwe Cassens, Peter Bröde, Maren Claus, Lea K. Picard, Sabine Wingert, Simone Backes, Deniz Durak, Nina Babel, Stefan Pöhlmann, Frank Renken, Stefan Raunser, Carsten Watzl |
20 |
[GO] |
2022―Feb―07 |
The presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19 |
Viktoria Hennings, Karolina Thörn, Sofie Albinsson, Christine Lingblom, Kerstin Andersson, Christer Andersson, et al. (+6) Katarina Järbur, Rille Pullerits, Manja Idorn, Soren R Paludan, Kristina Eriksson, Christine Wennerås |
21 |
[GO] |
2022―Jan―31 |
SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs |
Lieve E.H. Donk, Julia Eder, John L. Hamme, Philip J.M. Brouwer, Mitch Brinkkemper, Ad C. Nuenen, et al. (+5) Marit J. Gils, Rogier W. Sanders, Neeltje A. Kootstra, Marta Bermejo-Jambrina, Teunis B.H. Geijtenbeek |
22 |
[GO] |
2021―Dec―15 |
COVID-19 Vaccine Inequity: High time to calibrate the global moral compass |
Mayda Gursel |
23 |
[GO] |
2021―Dec―06 |
Metabolic reprograming shapes neutrophil functions in severe COVID-19 |
Rebecca Borella, Sara De Biasi, Annamaria Paolini, Federica Boraldi, Domenico Lo Tartaro, Marco Mattioli, et al. (+14) Lucia Fidanza, Anita Neroni, Alfredo Caro-Maldonado, Marianna Meschiari, Erica Franceschini, Daniela Quaglino, Giovanni Guaraldi, Carlo Bertoldi, Marco Sita, Stefano Busani, Massimo Girardis, Cristina Mussini, Andrea Cossarizza, Lara Gibellini |
24 |
[GO] |
2021―Dec―06 |
Robust induction of neutralizing antibodies against the SARS-CoV-2 Delta variant after homologous Spikevax or heterologous Vaxzevria-Spikevax vaccination |
Swantje I. Hammerschmidt, Christoph Thurm, Berislav Bošnjak, Günter Bernhardt, Annegret Reinhold, Stefanie Willenzon, et al. (+4) Christiane Ritter, Dirk Reinhold, Burkhart Schraven, Reinhold Förster |
25 |
[GO] |
2021―Nov―27 |
COVID-19 specific metabolic imprint yields insights into multi organ-system perturbations |
Martin Cornillet, Benedikt Strunz, Olav Rooyackers, Andrea Ponzetta, Puran Chen, Jagadeeswara Rao Muvva, et al. (+28) Mira Akber, Marcus Buggert, Benedict J. Chambers, Majda Dzidic, Iva Filipovic, Jean-Baptiste Gorin, Sara Gredmark-Russ, Laura Hertwig, Jonas Klingström, Efthymia Kokkinou, Egle Kvedaraite, Magda Lourda, Jenny Mjösberg, Christopher Maucourant, Anna Norrby-Teglund, Tiphaine Parrot, André Perez-Potti, Olga Rivera-Ballesteros, Johan K. Sandberg, John Tyler Sandberg, Takuya Sekine, Mattias Svensson, Renata Varnaite, Lars I. Eriksson, Soo Aleman, Kristoffer Strålin, Hans-Gustaf Ljunggren, Niklas K. Björkström |
26 |
[GO] |
2021―Nov―25 |
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection |
Michele Spinicci, Alessio Mazzoni, Beatrice Borchi, Lucia Graziani, Marcello Mazzetti, Filippo Bartalesi, et al. (+10) Annarita Botta, Marta Tilli, Filippo Pieralli, Marco Coppi, Nicla Giovacchini, Maria Grazia Colao, Riccardo Saccardi, Gian Maria Rossolini, Francesco Annunziato, Alessandro Bartoloni |
27 |
[GO] |
2021―Oct―25 |
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after infection |
Luísa Canto e Castro, Andreia Gomes, Marta Serrano, Ana Helena Guia Pereira, Rita Ribeiro, Patrícia Napoleão, et al. (+13) Inês Domingues, Cláudia Silva, Júlia Fanczal, Ângela Afonso, Andreia Lopes, Ionela Toader, Maria José Rego Sousa, José Germano Rego Sousa, Germano Sousa, Maria M. Mota, Bruno Silva-Santos, Marc Veldhoen, Ruy M. Ribeiro |
28 |
[GO] |
2021―Oct―22 |
Altered increase in STAT1 expression and phosphorylation in severe COVID-19 |
Hector Rincon-Arevalo, Arman Aue, Jacob Ritter, Franziska Szelinski, Dmytro Khadzhynov, Daniel Zickler, et al. (+7) Luisa Stefanski, Andreia C. Lino, Sixten Körper, Kai-Uwe Eckardt, Hubert Schrezenmeier, Thomas Dörner, Eva V. Schrezenmeier |
29 |
[GO] |
2021―Oct―04 |
Characterization of SARS-CoV-2 and common cold coronavirus-specific T cell responses in MIS-C and Kawasaki disease children |
Li-En Hsieh, Alba Grifoni, John Sidney, Chisato Shimizu, Hiroko Shike, Nanda Ramchandar, et al. (+4) Elizabeth Moreno, Adriana H. Tremoulet, Jane C. Burns, Alessandra Franco |
30 |
[GO] |
2021―Sep―28 |
Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans |
Anu Haveri, Nina Ekström, Anna Solastie, Camilla Virta, Pamela Österlund, Elina Isosaari, et al. (+3) Hanna Nohynek, Arto A Palmu, Merit Melin |
31 |
[GO] |
2021―Sep―26 |
SARS-CoV2 pneumonia recovery is linked to expansion of Innate Lymphoid Cells type 2 expressing CCR10 |
André MC Gomes, Guilherme B. Farias, Manuel Dias-Silva, Joel Laia, Amelia C. Trombetta, Ana Godinho-Santos, et al. (+9) Pedro Rosmaninho, Diana F. Santos, Carolina M. Conceição, Renato Costa-Reis, Maria Adão-Serrano, Catarina Mota, Afonso R.M. Almeida, Ana E. Sousa, Susana M. Fernandes |
32 |
[GO] |
2021―Sep―21 |
A surrogate cell-based SARS-CoV-2 spike blocking assay (SUBA) |
Wolfgang Schuh, Lena Baus, Tobit Steinmetz, Sebastian R. Schulz, Leonie Weckwerth, Edith Roth, et al. (+10) Manuela Hauke, Sara Krause, Patrick Morhart, Manfred Rauh, Markus Hoffmann, Niklas Vesper, Michael Reth, Holm Schneider, Hans-Martin Jäck, Dirk Mielenz |
33 |
[GO] |
2021―Aug―23 |
SARS-CoV-2-reactive T cell receptors isolated from convalescent COVID-19 patients confer potent T cell effector function |
Fabian Brunk, Andreas Moritz, Annika Nelde, Tatjana Bilich, Nicolas Casadei, Sabine A. K. Fraschka, et al. (+8) Jonas S. Heitmann, Sebastian Hörber, Andreas Peter, Hans-Georg Rammensee, Harpreet Singh, Juliane Walz, Dominik Maurer, Claudia Wagner |
34 |
[GO] |
2021―Aug―13 |
Specific detection of memory T-cells in COVID-19 patients using standardized whole-blood Interferon gamma release assay |
William Mouton, Christelle Compagnon, Kahina Saker, Soizic Daniel, Sophia Djebali, Xavier Lacoux, et al. (+13) Bruno Pozzetto, Guy Oriol, Daphné Laubreton, Margaux Prieux, Jean-Baptiste Fassier, Nicolas Guibert, Amélie Massardier-Pilonchéry, Dulce Alfaiate, Franck Berthier, Thierry Walzer, Jacqueline Marvel, Karen Brengel-Pesce, Sophie Trouiller-Assant |
35 |
[GO] |
2021―Aug―06 |
A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model |
Antonia Sophia Peter, Edith Roth, Sebastian R. Schulz, Kirsten Fraedrich, Tobit Steinmetz, Dominik Damm, et al. (+29) Manuela Hauke, Elie Richel, Sandra Mueller-Schmucker, Katharina Habenicht, Valentina Eberlein, Leila Issmail, Nadja Uhlig, Simon Dolles, Eva Grüner, David Peterhoff, Sandra Ciesek, Markus Hoffmann, Stefan Pöhlmann, Paul F. McKay, Robin J. Shattock, Roman Wölfel, Eileen Socher, Ralf Wagner, Jutta Eichler, Heinrich Sticht, Wolfgang Schuh, Frank Neipel, Armin Ensser, Dirk Mielenz, Matthias Tenbusch, Thomas H. Winkler, Thomas Grunwald, Klaus Überla, Hans-Martin Jäck |
36 |
[GO] |
2021―Aug―06 |
Single-reaction multi-antigen serological test for comprehensive evaluation of SARS-CoV-2 patients by flow cytometry |
Yaiza Cáceres-Martell, Daniel Fernández-Soto, Carmen Campos-Silva, Eva M. García-Cuesta, Jose M Casasnovas, David Navas-Herrera, et al. (+10) Alexandra Beneítez-Martínez, Pedro Martínez-Fleta, Arantzazu Alfranca, Francisco Sánchez-Madrid, Gabriela Escudero López, Carlos Vilches, Ricardo Jara-Acevedo, Hugh T. Reyburn, José M. Rodríguez Frade, Mar Valés-Gómez |
37 |
[GO] |
2021―Aug―05 |
Successful treatment of COVID-19 infection with convalescent plasma in B cell-depleted patients may promote cellular immunity |
Andreas E. Kremer, Anita N. Kremer, Carsten Willam, Simon Völkl, Johan Verhagen, Susanne Achenbach, et al. (+15) Edith D. Meijden, Vanessa Lang, Michael Aigner, Clara Maier, Matthias Tenbusch, Klaus Korn, Gloria Lutzny-Geier, Silvia Spoerl, Richard Strauß, Marcel Vetter, Klaus Überla, Markus F. Neurath, Andreas Mackensen, Mario Schiffer, Holger Hackstein |
38 |
[GO] |
2021―Aug―01 |
Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing |
Laura Marongiu, Giulia Protti, Fabio A. Facchini, Mihai Valache, Francesca Mingozzi, Valeria Ranzani, et al. (+16) Anna Rita Putignano, Lorenzo Salviati, Valeria Bevilacqua, Serena Curti, Mariacristina Crosti, Maria Lucia Sarnicola, Mariella D'Angiò, Laura Rachele Bettini, Andrea Biondi, Luca Nespoli, Nicolò Tamini, Nicola Clementi, Nicasio Mancini, Sergio Abrignani, Roberto Spreafico, Francesca Granucci |
39 |
[GO] |
2021―Jun―09 |
Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein |
Karol Palasiewicz, Sadiq Umar, Bianca Romay, Ryan K. Zomorrodi, Shiva Shahrara |
40 |
[GO] |
2021―Jun―05 |
Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice |
Huibin Lv, Owen Tak-Yin Tsang, Ray T. Y. So, Yiquan Wang, Meng Yuan, Hejun Liu, et al. (+10) Garrick K. Yip, Qi Wen Teo, Yihan Lin, Weiwen Liang, Jinlin Wang, Wilson W. Ng, Ian A. Wilson, J. S. Malik Peiris, Nicholas C. Wu, Chris K. P. Mok |
41 |
[GO] |
2021―Mar―31 |
Increased B Cell activity with consumption of activated monocytes in severe COVID-19 patients |
Igor Kos, Benedikt Balensiefer, Vadim Lesan, Dominic Kaddu-Mulindwa, Lorenz Thurner, Konstantin Christofyllakis, et al. (+15) Joerg Thomas Bittenbring, Manfred Ahlgrimm, Martina Seiffert, Stefan Wagenpfeil, Yvonne Bewarder, Frank Neumann, Torben Rixecker, Sigrun Smola, Andreas Link, Marcin Krawczyk, Frank Lammert, Philipp M. Lepper, Robert Bals, Stephan Stilgenbauer, Moritz Bewarder |
42 |
[GO] |
2021―Mar―31 |
Antigen-dependent multistep differentiation of T follicular helper cells and its role in SARS-CoV-2 infection and vaccination |
Dirk Baumjohann, Nicolas Fazilleau |
43 |
[GO] |
2021―Mar―30 |
Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung-homing in patients with severe acute SARS-CoV-2 infection |
Silvia Spoerl, Anita N. Kremer, Michael Aigner, Nina Eisenhauer, Pauline Koch, Lina Meretuk, et al. (+15) Patrick Löffler, Matthias Tenbusch, Clara Maier, Klaus Überla, Lucie Heinzerling, Benjamin Frey, Gloria Lutzny-Geier, Thomas H. Winkler, Gerhard Krönke, Marcel Vetter, Heiko Bruns, Markus F. Neurath, Andreas Mackensen, Andreas E. Kremer, Simon Völkl |
44 |
[GO] |
2021―Mar―27 |
Peptide microarray based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development |
Pavlo Holenya, Paul Joris Lange, Ulf Reimer, Wolfram Woltersdorf, Thomas Panterodt, Michael Glas, et al. (+10) Mark Wasner, Maren Eckey, Michael Drosch, Jörg-Michael Hollidt, Michael Naumann, Florian Kern, Holger Wenschuh, Robert Lange, Karsten Schnatbaum, Frank F. Bier |
45 |
[GO] |
2021―Mar―27 |
A Single Subcutaneous or Intranasal Immunization with Adenovirus-Based SARS-CoV-2 Vaccine Induces Robust Humoral and Cellular Immune Responses in Mice |
Eun Kim, Florian J. Weisel, Stephen C. Balmert, Muhammad S. Khan, Shaohua Huang, Geza Erdos, et al. (+14) Thomas W. Kenniston, Cara Donahue Carey, Stephen M. Joachim, Laura J. Conter, Nadine M. Weisel, Nisreen M.A. Okba, Bart L. Haagmans, Elena Percivalle, Irene Cassaniti, Fausto Baldanti, Emrullah Korkmaz, Mark J. Shlomchik, Louis D. Falo, Andrea Gambotto |
46 |
[GO] |
2021―Mar―26 |
Enrichment of CCR6+CD8+ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19 |
Anno Saris, Tom D.Y. Reijnders, Martine Reijm, Jolien C. Hollander, Kim Buck, Alex R. Schuurman, et al. (+7) JanWillem Duitman, Leo Heunks, Jurjan Aman, Harm Jan Bogaard, Esther J. Nossent, Tom Poll, Hetty J. Bontkes |
47 |
[GO] |
2021―Mar―19 |
Complement cascade in severe forms of COVID-19: recent advances in therapy |
Nassima Chouaki Benmansour, Julien Carvelli, Eric Vivier |
48 |
[GO] |
2021―Mar―09 |
Insights into coronavirus immunity taught by the murine coronavirus |
Sarah Grabherr, Burkhard Ludewig, Natalia Barbara Pikor |
49 |
[GO] |
2021―Mar―06 |
Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection |
Farzan Solimani, Katharina Meier, Kamran Ghoreschi |
50 |
[GO] |
2021―Mar―03 |
Organizing the 16th Spring School on Immunology during a pandemic |
Michael Lohoff, Melanie Wolf, Tanja Durez |
51 |
[GO] |
2021―Feb―14 |
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2 |
Bernard Vanhove, Odile Duvaux, Juliette Rousse, Pierre-Joseph Royer, Gwénaëlle Evanno, Carine Ciron, et al. (+23) Elsa Lheriteau, Laurent Vacher, Nadine Gervois, Romain Oger, Yannick Jacques, Sophie Conchon, Apolline Salama, Roberto Duchi, Irina Lagutina, Andrea Perota, Philippe Delahaut, Matthieu Ledure, Melody Paulus, Ray T. So, Chris Ka-Pun Mok, Roberto Bruzzone, Marc Bouillet, Sophie Brouard, Emanuele Cozzi, Cesare Galli, Dominique Blanchard, Jean-Marie Bach, Jean-Paul Soulillou |
52 |
[GO] |
2021―Jan―15 |
Impact of COVID-19 pandemic on EJI and the extended immunological community |
|
53 |
[GO] |
2021―Jan―15 |
Academic labs supporting COVID-19 diagnostics |
Marc Veldhoen, Vanessa Zuzarte-Luis |
54 |
[GO] |
2020―Dec―25 |
Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19 |
O Blagova, N Varionchik, V Zaidenov, P Savina, N Sarkisova |
55 |
[GO] |
2020―Dec―13 |
Type-I Interferon assessment in 45 minutes using the FilmArray
®
PCR platform in SARS-CoV-2 and other viral infections |
Marine Mommert, Magali Perret, Matthew Hockin, Sébastien Viel, Alexandre Belot, Jean-Christophe Richard, et al. (+7) Mehdi Mezidi, Jean-Baptiste Fassier, Etienne Javouhey, Andrew Hemmert, François Mallet, Sophie Trouillet-Assant, Karen Brengel-Pesce |
56 |
[GO] |
2020―Dec―11 |
European female immunologists share their experiences during COVID-19 lock-downs |
|
57 |
[GO] |
2020―Dec―11 |
The impact of COVID-19 lock-downs for European (female) immunologists - our views as members of the EFIS gender and diversity task force |
Charlotte Esser, A. Mieke Boots, Anne Caignard, Ceren Ciraci, Danka Grčević, Sylvia Knapp, et al. (+5) Maria Montoya, Francesca Di Rosa, Tamara Saksida, Dovile Stravinskiene, Günnur Deniz |
58 |
[GO] |
2020―Dec―01 |
High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris |
François Anna, Sophie Goyard, Ana Ines Lalanne, Fabien Nevo, Marion Gransagne, Philippe Souque, et al. (+19) Delphine Louis, Véronique Gillon, Isabelle Turbiez, François-Clément Bidard, Aline Gobillion, Alexia Savignoni, Maude Guillot-Delost, François Dejardin, Evelyne Dufour, Stéphane Petres, Odile Richard-Le Goff, Zaineb Choucha, Olivier Helynck, Yves L. Janin, Nicolas Escriou, Pierre Charneau, Franck Perez, Thierry Rose, Olivier Lantz |
59 |
[GO] |
2020―Nov―30 |
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients |
Ana Marcos-Jiménez, Santiago Sánchez-Alonso, Ana Alcaraz-Serna, Laura Esparcia, Celia López-Sanz, Miguel Sampedro-Núñez, et al. (+18) Tamara Mateu-Albero, Ildefonso Sánchez-Cerrillo, Pedro Martínez-Fleta, Ligia Gabrie, Luciana del Campo Guerola, José Miguel Rodríguez-Frade, José M. Casasnovas, Hugh T. Reyburn, Mar Valés-Gómez, Margarita López-Trascasa, Enrique Martín-Gayo, María José Calzada, Santos Castañeda, Hortensia de la Fuente, Isidoro González-Álvaro, Francisco Sánchez-Madrid, Cecilia Muñoz-Calleja, Arantzazu Alfranca |
60 |
[GO] |
2020―Oct―21 |
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to six months post disease onset |
Patrícia Figueiredo-Campos, Birte Blankenhaus, Catarina Mota, Andreia Gomes, Marta Serrano, Silvia Ariotti, et al. (+15) Catarina Costa, Helena Nunes-Cabaço, António M. Mendes, Pedro Gaspar, M. Conceição Pereira-Santos, Fabiana Rodrigues, Jorge Condeço, M. Antonia Escoval, Matilde Santos, Mario Ramirez, José Melo-Cristino, J. Pedro Simas, Eugenia Vasconcelos, Ângela Afonso, Marc Veldhoen |
61 |
[GO] |
2020―Oct―20 |
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients |
Alessio Mazzoni, Laura Maggi, Manuela Capone, Michele Spinicci, Lorenzo Salvati, Maria Grazia Colao, et al. (+14) Anna Vanni, Seble Tekle Kiros, Jessica Mencarini, Lorenzo Zammarchi, Elisabetta Mantengoli, Lorenzo Menicacci, Eleonora Caldini, Sergio Romagnani, Francesco Liotta, Alessandro Morettini, Gian Maria Rossolini, Alessandro Bartoloni, Lorenzo Cosmi, Francesco Annunziato |
62 |
[GO] |
2020―Oct―19 |
Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19 patients |
Anna E. Oja, Anno Saris, Cherien A. Ghandour, Natasja A.M. Kragten, Boris M. Hogema, Esther J. Nossent, et al. (+12) Leo M.A. Heunks, Susan Cuvalay, Ed Slot, Federica Linty, Francis H. Swaneveld, Hans Vrielink, Gestur Vidarsson, Theo Rispens, Ellen Schoot, René A.W. Lier, Anja Ten Brinke, Pleun Hombrink |
63 |
[GO] |
2020―Sep―04 |
Convalescent plasma treatment for COVID-19: tempering expectations with the influenza experience |
Kanta Subbarao, Francesca Mordant, Rajeev Rudraraju |
64 |
[GO] |
2020―Jul―24 |
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia |
Sara De Biasi, Domenico Lo Tartaro, Marianna Meschiari, Lara Gibellini, Caterina Bellinazzi, Rebecca Borella, et al. (+15) Lucia Fidanza, Marco Mattioli, Annamaria Paolini, Licia Gozzi, Dina Jaacoub, Matteo Faltoni, Sara Volpi, Jovana Milić, Marco Sita, Mario Sarti, Carlo Pucillo, Massimo Girardis, Giovanni Guaraldi, Cristina Mussini, Andrea Cossarizza |
65 |
[GO] |
2020―Jun―27 |
Immune response in children with COVID-19 is characterized by lower levels of T cell activation than infected adults |
Daniele Moratto, Mauro Giacomelli, Marco Chiarini, Lucia Savarè, Barbara Saccani, Mario Motta, et al. (+8) Silviana Timpano, Piercarlo Poli, Simone Paghera, Luisa Imberti, Stefania Cannizzo, Eugenia Quiros-Roldan, Giulia Marchetti, Raffaele Badolato |
66 |
[GO] |
2020―Jun―25 |
LIPS method for the detection of SARS-CoV-2 antibodies to spike and nucleocapsid proteins |
Liis Haljasmägi, Anu Remm, Anna Pauliina Rumm, Ekaterina Krassohhina, Hanna Sein, Anu Tamm, et al. (+2) Kai Kisand, Pärt Peterson |
67 |
[GO] |
2020―May―21 |
Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity |
Virgil Schijns, Ed C. Lavelle |
68 |
[GO] |
2020―May―21 |
COVID-19 vaccines: knowing the unknown |
Huibin Lv, Nicholas C. Wu, Chris K. P. Mok |
69 |
[GO] |
2020―Apr―27 |
An address to the European immunology community concerning the Coronavirus pandemic |
|
70 |
[GO] |
2020―Apr―27 |
Angry viruses make us sick: a child's depiction of SARS-CoV-2 |
|
71 |
[GO] |
2020―Feb―27 |
COVID-19: Lessons from SARS and MERS |
Mirae Park, Ryan S. Thwaites, Peter J. M. Openshaw |
|